Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy.

× No keyword cloud information.

37 in total

Review 1. Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fibrosis in kidney disease.

Authors: P J Stahl; D Felsen
Journal: Am J Pathol Date: 2001-10 Impact factor: 4.307

Review 2. Uric acid as a mediator of diabetic nephropathy.

Authors: Diana I Jalal; David M Maahs; Peter Hovind; Takahiko Nakagawa
Journal: Semin Nephrol Date: 2011-09 Impact factor: 5.299

3. The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling.

Authors: Petros Andrikopoulos; Julius Kieswich; Sabrina Pacheco; Luxme Nadarajah; Steven Michael Harwood; Caroline E O'Riordan; Christoph Thiemermann; Muhammad M Yaqoob
Journal: J Am Soc Nephrol Date: 2018-12-10 Impact factor: 10.121

Review 4. Diabetic nephropathy and extracellular matrix.

Authors: S O Kolset; F P Reinholt; T Jenssen
Journal: J Histochem Cytochem Date: 2012-10-27 Impact factor: 2.479

5. Knockdown of elF3a inhibits collagen synthesis in renal fibroblasts via Inhibition of transforming growth factor-β1/Smad signaling pathway.

Authors: Yun-Fang Zhang; Qi Wang; Jie Luo; Shen Yang; Jie-Lin Wang; Hong-Yan Li
Journal: Int J Clin Exp Pathol Date: 2015-08-01

6. Pathogenic role of mast cells in the development of diabetic nephropathy: a study of patients at different stages of the disease.

Authors: J M Zheng; G H Yao; Z Cheng; R Wang; Z H Liu
Journal: Diabetologia Date: 2011-12-01 Impact factor: 10.122

Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy.

Review 1. Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fibrosis in kidney disease.

Review 2. Uric acid as a mediator of diabetic nephropathy.

3. The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling.

Review 4. Diabetic nephropathy and extracellular matrix.

5. Knockdown of elF3a inhibits collagen synthesis in renal fibroblasts via Inhibition of transforming growth factor-β1/Smad signaling pathway.

6. Pathogenic role of mast cells in the development of diabetic nephropathy: a study of patients at different stages of the disease.

7. Role of upstream stimulatory factor 2 in diabetic nephropathy.

Review 8. TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis.

Review 9. Therapeutic targets for treating fibrotic kidney diseases.

Review 10. A glimpse of matrix metalloproteinases in diabetic nephropathy.